Chapter 1. Introduction
1.1. Research Objective
1.2. Scope of the Study
1.3. Definition
Chapter 2. Research Methodology
2.1. Research Approach
2.2. Data Sources
2.3. Assumptions & Limitations
Chapter 3. Executive Summary
3.1. Market Snapshot
Chapter 4. Market Variables and Scope
4.1. Introduction
4.2. Market Classification and Scope
4.3. Industry Value Chain Analysis
4.3.1. Raw Material Procurement Analysis
4.3.2. Sales and Distribution Channel Analysis
4.3.3. Downstream Buyer Analysis
Chapter 5. Market Dynamics Analysis and Trends
5.1. Market Dynamics
5.1.1. Market Drivers
5.1.2. Market Restraints
5.1.3. Market Opportunities
5.2. Porter’s Five Forces Analysis
5.2.1. Bargaining power of suppliers
5.2.2. Bargaining power of buyers
5.2.3. Threat of substitute
5.2.4. Threat of new entrants
5.2.5. Degree of competition
Chapter 6. Competitive Landscape
6.1.1. Company Market Share/Positioning Analysis
6.1.2. Key Strategies Adopted by Players
6.1.3. Vendor Landscape
6.1.3.1. List of Suppliers
6.1.3.2. List of Buyers
Chapter 7. Global Cell And Gene Therapy Manufacturing Market, By Therapy Type
7.1. Cell And Gene Therapy Manufacturing Market, By Therapy Type, 2020-2030
7.1.1. Cell Therapy Manufacturing
7.1.1.1. Market Revenue and Forecast (2016-2030)
7.1.2. Gene Therapy Manufacturing
7.1.2.1. Market Revenue and Forecast (2016-2030)
Chapter 8. Global Cell And Gene Therapy Manufacturing Market, By Scale Type
8.1. Cell And Gene Therapy Manufacturing Market, By Scale Type, 2020-2030
8.1.1. Pre-commercial/ R&D Scale Manufacturing
8.1.1.1. Market Revenue and Forecast (2016-2030)
8.1.2. Commercial Scale Manufacturing
8.1.2.1. Market Revenue and Forecast (2016-2030)
Chapter 9. Global Cell And Gene Therapy Manufacturing Market, By Mode
9.1. Cell And Gene Therapy Manufacturing Market, By Filling Material, 2020-2030
9.1.1. Contract Manufacturing
9.1.1.1. Market Revenue and Forecast (2016-2030)
9.1.2. In-house Manufacturing
9.1.2.1. Market Revenue and Forecast (2016-2030)
Chapter 10. Global Cell And Gene Therapy Manufacturing Market, By Workflow
10.1. Cell And Gene Therapy Manufacturing Market, By End-use, 2020-2030
10.1.1. Cell Processing
10.1.1.1. Market Revenue and Forecast (2016-2030)
10.1.2. Cell Banking
10.1.2.1. Market Revenue and Forecast (2016-2030)
10.1.3. Process Development
10.1.3.1. Market Revenue and Forecast (2016-2030)
10.1.4. Fill & Finish Operations
10.1.4.1. Market Revenue and Forecast (2016-2030)
10.1.5. Analytical And Quality Testing
10.1.5.1. Market Revenue and Forecast (2016-2030)
10.1.6. Raw Material Testing
10.1.6.1. Market Revenue and Forecast (2016-2030)
10.1.7. Vector Production
10.1.7.1. Market Revenue and Forecast (2016-2030)
Chapter 11. Global Cell And Gene Therapy Manufacturing Market, Regional Estimates and Trend Forecast
11.1. North America
11.1.1. Market Revenue and Forecast, By Therapy Type (2016-2030)
11.1.2. Market Revenue and Forecast, By Scale Type (2016-2030)
11.1.3. Market Revenue and Forecast, By Mode (2016-2030)
11.1.4. Market Revenue and Forecast, By Workflow(2016-2030)
11.1.5. U.S.
11.1.5.1. Market Revenue and Forecast, By Therapy Type (2016-2030)
11.1.5.2. Market Revenue and Forecast, By Scale Type (2016-2030)
11.1.5.3. Market Revenue and Forecast, By Mode (2016-2030)
11.1.5.4. Market Revenue and Forecast, By Workflow(2016-2030)
11.1.6. Rest of North America
11.1.6.1. Market Revenue and Forecast, By Therapy Type (2016-2030)
11.1.6.2. Market Revenue and Forecast, By Scale Type (2016-2030)
11.1.6.3. Market Revenue and Forecast, By Mode (2016-2030)
11.1.6.4. Market Revenue and Forecast, By Workflow(2016-2030)
11.2. Europe
11.2.1. Market Revenue and Forecast, By Therapy Type (2016-2030)
11.2.2. Market Revenue and Forecast, By Scale Type (2016-2030)
11.2.3. Market Revenue and Forecast, By Mode (2016-2030)
11.2.4. Market Revenue and Forecast, By Workflow(2016-2030)
11.2.5. UK
11.2.5.1. Market Revenue and Forecast, By Therapy Type (2016-2030)
11.2.5.2. Market Revenue and Forecast, By Scale Type (2016-2030)
11.2.5.3. Market Revenue and Forecast, By Mode (2016-2030)
11.2.5.4. Market Revenue and Forecast, By Workflow(2016-2030)
11.2.6. Germany
11.2.6.1. Market Revenue and Forecast, By Therapy Type (2016-2030)
11.2.6.2. Market Revenue and Forecast, By Scale Type (2016-2030)
11.2.6.3. Market Revenue and Forecast, By Mode (2016-2030)
11.2.6.4. Market Revenue and Forecast, By Workflow(2016-2030)
11.2.7. France
11.2.7.1. Market Revenue and Forecast, By Therapy Type (2016-2030)
11.2.7.2. Market Revenue and Forecast, By Scale Type (2016-2030)
11.2.7.3. Market Revenue and Forecast, By Mode (2016-2030)
11.2.7.4. Market Revenue and Forecast, By Workflow(2016-2030)
11.2.8. Rest of Europe
11.2.8.1. Market Revenue and Forecast, By Therapy Type (2016-2030)
11.2.8.2. Market Revenue and Forecast, By Scale Type (2016-2030)
11.2.8.3. Market Revenue and Forecast, By Mode (2016-2030)
11.2.8.4. Market Revenue and Forecast, By Workflow(2016-2030)
11.3. APAC
11.3.1. Market Revenue and Forecast, By Therapy Type (2016-2030)
11.3.2. Market Revenue and Forecast, By Scale Type (2016-2030)
11.3.3. Market Revenue and Forecast, By Mode (2016-2030)
11.3.4. Market Revenue and Forecast, By Workflow(2016-2030)
11.3.5. India
11.3.5.1. Market Revenue and Forecast, By Therapy Type (2016-2030)
11.3.5.2. Market Revenue and Forecast, By Scale Type (2016-2030)
11.3.5.3. Market Revenue and Forecast, By Mode (2016-2030)
11.3.5.4. Market Revenue and Forecast, By Workflow(2016-2030)
11.3.6. China
11.3.6.1. Market Revenue and Forecast, By Therapy Type (2016-2030)
11.3.6.2. Market Revenue and Forecast, By Scale Type (2016-2030)
11.3.6.3. Market Revenue and Forecast, By Mode (2016-2030)
11.3.6.4. Market Revenue and Forecast, By Workflow(2016-2030)
11.3.7. Japan
11.3.7.1. Market Revenue and Forecast, By Therapy Type (2016-2030)
11.3.7.2. Market Revenue and Forecast, By Scale Type (2016-2030)
11.3.7.3. Market Revenue and Forecast, By Mode 2016-2030)
11.3.7.4. Market Revenue and Forecast, By Workflow(2016-2030)
11.3.8. Rest of APAC
11.3.8.1. Market Revenue and Forecast, By Therapy Type (2016-2030)
11.3.8.2. Market Revenue and Forecast, By Scale Type (2016-2030)
11.3.8.3. Market Revenue and Forecast, By Mode (2016-2030)
11.3.8.4. Market Revenue and Forecast, By Workflow(2016-2030)
11.4. MEA
11.4.1. Market Revenue and Forecast, By Therapy Type (2016-2030)
11.4.2. Market Revenue and Forecast, By Scale Type (2016-2030)
11.4.3. Market Revenue and Forecast, By Mode (2016-2030)
11.4.4. Market Revenue and Forecast, By Workflow(2016-2030)
11.4.5. GCC
11.4.5.1. Market Revenue and Forecast, By Therapy Type (2016-2030)
11.4.5.2. Market Revenue and Forecast, By Scale Type (2016-2030)
11.4.5.3. Market Revenue and Forecast, By Mode (2016-2030)
11.4.5.4. Market Revenue and Forecast, By Workflow(2016-2030)
11.4.6. North Africa
11.4.6.1. Market Revenue and Forecast, By Therapy Type (2016-2030)
11.4.6.2. Market Revenue and Forecast, By Scale Type (2016-2030)
11.4.6.3. Market Revenue and Forecast, By Mode (2016-2030)
11.4.6.4. Market Revenue and Forecast, By Workflow(2016-2030)
11.4.7. South Africa
11.4.7.1. Market Revenue and Forecast, By Therapy Type (2016-2030)
11.4.7.2. Market Revenue and Forecast, By Scale Type (2016-2030)
11.4.7.3. Market Revenue and Forecast, By Mode (2016-2030)
11.4.7.4. Market Revenue and Forecast, By Workflow(2016-2030)
11.4.8. Rest of MEA
11.4.8.1. Market Revenue and Forecast, By Therapy Type (2016-2030)
11.4.8.2. Market Revenue and Forecast, By Scale Type (2016-2030)
11.4.8.3. Market Revenue and Forecast, By Mode (2016-2030)
11.4.8.4. Market Revenue and Forecast, By Workflow(2016-2030)
11.5. Latin America
11.5.1. Market Revenue and Forecast, By Therapy Type (2016-2030)
11.5.2. Market Revenue and Forecast, By Scale Type (2016-2030)
11.5.3. Market Revenue and Forecast, By Mode (2016-2030)
11.5.4. Market Revenue and Forecast, By Workflow(2016-2030)
11.5.5. Brazil
11.5.5.1. Market Revenue and Forecast, By Therapy Type (2016-2030)
11.5.5.2. Market Revenue and Forecast, By Scale Type (2016-2030)
11.5.5.3. Market Revenue and Forecast, By Mode (2016-2030)
11.5.5.4. Market Revenue and Forecast, By Workflow(2016-2030)
11.5.6. Rest of LATAM
11.5.6.1. Market Revenue and Forecast, By Therapy Type (2016-2030)
11.5.6.2. Market Revenue and Forecast, By Scale Type (2016-2030)
11.5.6.3. Market Revenue and Forecast, By Mode (2016-2030)
11.5.6.4. Market Revenue and Forecast, By Workflow(2016-2030)
Chapter 12. Company Profiles
12.1. Thermo Fisher Scientific
12.1.1. Company Overview
12.1.2. Product Offerings
12.1.3. Financial Performance
12.1.4. Recent Initiatives
12.2. Merck KGaA
12.2.1. Company Overview
12.2.2. Product Offerings
12.2.3. Financial Performance
12.2.4. Recent Initiatives
12.3. Lonza
12.3.1. Company Overview
12.3.2. Product Offerings
12.3.3. Financial Performance
12.3.4. Recent Initiatives
12.4. Catalent Inc.
12.4.1. Company Overview
12.4.2. Product Offerings
12.4.3. Financial Performance
12.4.4. Recent Initiatives
12.5. Takara Bio Inc.
12.5.1. Company Overview
12.5.2. Product Offerings
12.5.3. Financial Performance
12.5.4. Recent Initiatives
12.6. F. Hoffmann-La Roche Ltd
12.6.1. Company Overview
12.6.2. Product Offerings
12.6.3. Financial Performance
12.6.4. Recent Initiatives
12.7. Wuxi Advanced Therapies
12.7.1. Company Overview
12.7.2. Product Offerings
12.7.3. Financial Performance
12.7.4. Recent Initiatives
12.8. Samsung Biologics
12.8.1. Company Overview
12.8.2. Product Offerings
12.8.3. Financial Performance
12.8.4. Recent Initiatives
12.9. Boehringer Ingelheim
12.9.1. Company Overview
12.9.2. Product Offerings
12.9.3. Financial Performance
12.9.4. Recent Initiatives
12.10. Novartis AG
12.10.1. Company Overview
12.10.2. Product Offerings
12.10.3. Financial Performance
12.10.4. Recent Initiatives
12.11. Hitachi Chemical Co., Ltd.
12.11.1. Company Overview
12.11.2. Product Offerings
12.11.3. Financial Performance
12.11.4. Recent Initiatives
12.12. Cellular Therapeutics
12.12.1. Company Overview
12.12.2. Product Offerings
12.12.3. Financial Performance
12.12.4. Recent Initiatives
12.13. Miltenyi Biotec
12.13.1. Company Overview
12.13.2. Product Offerings
12.13.3. Financial Performance
12.13.4. Recent Initiatives
12.14. Bluebird Bio Inc.
12.14.1. Company Overview
12.14.2. Product Offerings
12.14.3. Financial Performance
12.14.4. Recent Initiatives
Chapter 13. Research Methodology
13.1. Primary Research
13.2. Secondary Research
13.3. Assumptions
Chapter 14. Appendix
14.1. About Us
14.2. Glossary of Terms